Prevalence and Incidence of Chronic Kidney Disease Stage 3-5 - Results from KidDiCo

Overview

Journal BMC Nephrol

Publisher Biomed Central

Specialty Nephrology

Date 2023 Jan 19

PMID 36658506

Authors

Jan Dominik Kampmann

James Goya Heaf

Christian Backer Mogensen

Hans Mickley

Donna Lykke Wolff

Frans Brandt

Affiliations

Soon will be listed here.

Abstract

Background: Chronic kidney disease (CKD) is a global challenge. CKD prevalence estimation is central to management strategies and prevention. It is necessary to predict end stage kidney disease (ESKD) and, subsequently, the burden for healthcare systems. In this study we characterize CKD stage 3-5 prevalence and incidence in a cohort covering the majority of the Region of Southern Denmark and investigate individuals' demographic, socioeconomic, and comorbidity status.

Methods: We used data from the Kidney Disease Cohort (KidDiCo) combining laboratory data from Southern Denmark with Danish national databases. Chronic kidney disease was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines.

Results: The prevalence varied between 4.83 and 4.98% and incidence rate of CKD was 0.49%/year. The median age was 76.4 years. The proportion of individuals with CKD stage 3-5 in the entire population increased consistently with age. The percentage of women in the CKD 3-5 group was higher than in the background population. Diabetes mellitus, hypertension and cardiovascular disease were more prominent in patients with CKD. CKD stage 5 and ESKD were more frequent as incident CKD stages in the 18-49 year olds when compared to older individuals. CKD patients tended to have a lower socioeconomic status.

Conclusion: Chronic kidney disease stage 3-5 is common, especially in the elderly. Patients with CKD stage 3-5 are predominantly female. The KidDiCo data suggests an association between lower socioeconomic status and prevalence of CKD.

Citing Articles

Prevalence of Chronic Kidney Disease Among Elderly Patients in the Northeastern Region of Romania: A Descriptive, Cross-Sectional, Retrospective Analysis.

Nistor I, Turcu A, Stefan A, Covic A, Agavriloaei B, Mahu G Cureus. 2025; 17(3):e80412.

PMID: 40070888 PMC: 11896089. DOI: 10.7759/cureus.80412.

The management of chronic kidney disease in primary care in Denmark: patient characteristics, treatment, follow-up, progression and referral.

Birn H, Nelveg-Kristensen K, Frederiksen L, Christensen S, Mehtala J, Smith S Clin Kidney J. 2025; 18(2):sfae393.

PMID: 39906072 PMC: 11788563. DOI: 10.1093/ckj/sfae393.

Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential.

Fuerlinger A, Stockner A, Sedej S, Abdellatif M Cardiovasc Diabetol. 2025; 24(1):21.

PMID: 39827109 PMC: 11742808. DOI: 10.1186/s12933-024-02566-8.

Increased Risk of End-Stage Kidney Disease After Traumatic Amputation: Nationwide Cohort Study.

Yoo J, Kim B, Chang W, Lee K, Jang H, Han K Healthcare (Basel). 2025; 13(1.

PMID: 39791687 PMC: 11720595. DOI: 10.3390/healthcare13010080.

Economic burden of Type 2 diabetes in Iran in 2022.

Mohammadi A, Goharimehr M, Darvishi A, Heshmat R, Nasli Esfahani E, Shafiee G BMC Public Health. 2025; 25(1):35.

PMID: 39755620 PMC: 11699660. DOI: 10.1186/s12889-024-21247-5.

References

Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

Vassalotti J, Li S, McCullough P, Bakris G . Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin Nephrol. 2010; 30(1):66-73. DOI: 10.1016/j.semnephrol.2009.10.004. View

Bruck K, Stel V, Gambaro G, Hallan S, Volzke H, Arnlov J . CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2015; 27(7):2135-47. PMC: 4926978. DOI: 10.1681/ASN.2015050542. View

Bello A, Levin A, Tonelli M, Okpechi I, Feehally J, Harris D . Assessment of Global Kidney Health Care Status. JAMA. 2017; 317(18):1864-1881. PMC: 5470418. DOI: 10.1001/jama.2017.4046. View

Kampmann J, Heaf J, Mogensen C, Mickley H, Brandt F . Kidney Disease Cohort (KidDiCo) of Southern Denmark: Design, Coverage, Generalizability and Implications for Use. Clin Epidemiol. 2021; 13:971-980. PMC: 8525414. DOI: 10.2147/CLEP.S328512. View

Carrero J, Hecking M, Chesnaye N, Jager K . Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018; 14(3):151-164. DOI: 10.1038/nrneph.2017.181. View

Henriksen D, Damkier P, Hallas J, Nybo M . Sixteen years of creatinine measurements among 460 000 individuals-The Funen Laboratory Cohort (FLaC), a population-based pharmacoepidemiological resource to study drug-induced kidney disease. Basic Clin Pharmacol Toxicol. 2018; 124(5):582-590. DOI: 10.1111/bcpt.13167. View

Moller-Leimkuhler A . Barriers to help-seeking by men: a review of sociocultural and clinical literature with particular reference to depression. J Affect Disord. 2002; 71(1-3):1-9. DOI: 10.1016/s0165-0327(01)00379-2. View

Stack A, Casserly L, Cronin C, Chernenko T, Cullen W, Hannigan A . Prevalence and variation of Chronic Kidney Disease in the Irish health system: initial findings from the National Kidney Disease Surveillance Programme. BMC Nephrol. 2014; 15:185. PMC: 4258258. DOI: 10.1186/1471-2369-15-185. View

10.

Lee W, Lee Y, Li L, Ng H, Kuo W, Lin P . The Number of Comorbidities Predicts Renal Outcomes in Patients with Stage 3⁻5 Chronic Kidney Disease. J Clin Med. 2018; 7(12). PMC: 6306906. DOI: 10.3390/jcm7120493. View

11.

McCullough K, Sharma P, Ali T, Khan I, Smith W, MacLeod A . Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant. 2011; 27(5):1812-21. DOI: 10.1093/ndt/gfr547. View

12.

Saran R, Li Y, Robinson B, Abbott K, Agodoa L, Ayanian J . US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2016; 67(3 Suppl 1):Svii, S1-305. PMC: 6643990. DOI: 10.1053/j.ajkd.2015.12.014. View

13.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014; 12(12):1495-9. DOI: 10.1016/j.ijsu.2014.07.013. View

14.

Neugarten J, Acharya A, Silbiger S . Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000; 11(2):319-329. DOI: 10.1681/ASN.V112319. View

15.

Kainz A, Hronsky M, Stel V, Jager K, Geroldinger A, Dunkler D . Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025. Nephrol Dial Transplant. 2015; 30 Suppl 4:iv113-8. DOI: 10.1093/ndt/gfv073. View

16.

Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

17.

Forouzanfar M, Alexander L, Anderson H, Bachman V, Biryukov S, Brauer M . Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(10010):2287-323. PMC: 4685753. DOI: 10.1016/S0140-6736(15)00128-2. View

18.

Matsushita K, Sang Y, Ballew S, Astor B, Hoogeveen R, Solomon S . Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study. Arterioscler Thromb Vasc Biol. 2014; 34(8):1770-7. PMC: 4172337. DOI: 10.1161/ATVBAHA.114.303465. View

19.

Thygesen L, Daasnes C, Thaulow I, Bronnum-Hansen H . Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health. 2011; 39(7 Suppl):12-6. DOI: 10.1177/1403494811399956. View

20.

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View